Chemoinformaics analysis of (Z)-HEXADEC-9-ENOIC-ACID
| Molecular Weight | 1660.71 | nRot | 85 |
| Heavy Atom Molecular Weight | 1465.15 | nRig | 2 |
| Exact Molecular Weight | 1659.46 | nRing | 0 |
| Solubility: LogS | -6.362 | nHRing | 0 |
| Solubility: LogP | 8.712 | No. of Aliphatic Rings | 0 |
| Acid Count | 6 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 312 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 118 | No. of Aromatic Carbocycles | 0 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 194 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 106 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 316.002 |
| nHD | 6 | BPOL | 199.83 |
| QED | 0.194 |
| Synth | 2.099 |
| Natural Product Likeliness | 0.725 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.055 |
| MDCK | 0.0000178 |
| BBB | 0.028 |
| PPB | 0.99173 |
| VDSS | 1.141 |
| FU | 0.0101924 |
| CYP1A2-inh | 0.232 |
| CYP1A2-sub | 0.165 |
| CYP2c19-inh | 0.26 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.116 |
| CYP2c9-sub | 0.993 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.046 |
| CYP3a4-inh | 0.092 |
| CYP3a4-sub | 0.01 |
| CL | 2.605 |
| T12 | 0.309 |
| hERG | 0.083 |
| Ames | 0.004 |
| ROA | 0.011 |
| SkinSen | 0.961 |
| Carcinogencity | 0.059 |
| EI | 0.939 |
| Respiratory | 0.654 |
| NR-Aromatase | 0.214 |
| Antiviral | Yes |
| Prediction | 0.586967 |